203 related articles for article (PubMed ID: 21506294)
1. Chemotherapy-induced cardiomyopathy.
Yusuf SW; Ilias-Khan NA; Durand JB
Expert Rev Cardiovasc Ther; 2011 Feb; 9(2):231-43. PubMed ID: 21506294
[TBL] [Abstract][Full Text] [Related]
2. Advanced heart failure therapies for patients with chemotherapy-induced cardiomyopathy.
Oliveira GH; Qattan MY; Al-Kindi S; Park SJ
Circ Heart Fail; 2014 Nov; 7(6):1050-8. PubMed ID: 25415958
[No Abstract] [Full Text] [Related]
3. Cancer Therapy-Related Cardiac Dysfunction and Heart Failure: Part 2: Prevention, Treatment, Guidelines, and Future Directions.
Hamo CE; Bloom MW; Cardinale D; Ky B; Nohria A; Baer L; Skopicki H; Lenihan DJ; Gheorghiade M; Lyon AR; Butler J
Circ Heart Fail; 2016 Feb; 9(2):e002843. PubMed ID: 26839395
[TBL] [Abstract][Full Text] [Related]
4. [Non-compaction cardiomyopathy].
Wieneke H; Neumann T; Breuckmann F; Hunold P; Fries JW; Dirsch O; Erbel R
Herz; 2005 Sep; 30(6):571-4. PubMed ID: 16170691
[TBL] [Abstract][Full Text] [Related]
5. A Practical Approach to the Oncology Patient With Heart Failure.
Carter LP; Clarke BA
Can J Cardiol; 2015 Dec; 31(12):1489-92. PubMed ID: 26321357
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chemotherapy-associated cardiomyopathy.
Cai AW; Taylor MH; Ramu B
Curr Opin Cardiol; 2019 May; 34(3):296-302. PubMed ID: 30747732
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs.
Molinaro M; Ameri P; Marone G; Petretta M; Abete P; Di Lisa F; De Placido S; Bonaduce D; Tocchetti CG
Biomed Res Int; 2015; 2015():138148. PubMed ID: 26583088
[TBL] [Abstract][Full Text] [Related]
8. Heart Failure Therapies for End-Stage Chemotherapy-Induced Cardiomyopathy.
Mukku RB; Fonarow GC; Watson KE; Ajijola OA; Depasquale EC; Nsair A; Baas AS; Deng MC; Yang EH
J Card Fail; 2016 Jun; 22(6):439-48. PubMed ID: 27109619
[TBL] [Abstract][Full Text] [Related]
9. The cardiotoxicity of anticancer agents.
Von Hoff DD; Rozencweig M; Piccart M
Semin Oncol; 1982 Mar; 9(1):23-33. PubMed ID: 7071608
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-induced cardiomyopathy.
Higgins AY; O'Halloran TD; Chang JD
Heart Fail Rev; 2015 Nov; 20(6):721-30. PubMed ID: 26338137
[TBL] [Abstract][Full Text] [Related]
11. Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge.
Tocchetti CG; Ragone G; Coppola C; Rea D; Piscopo G; Scala S; De Lorenzo C; Iaffaioli RV; Arra C; Maurea N
Eur J Heart Fail; 2012 Feb; 14(2):130-7. PubMed ID: 22219501
[TBL] [Abstract][Full Text] [Related]
12. Detection and prevention of cardiac complications of cancer chemotherapy.
Monsuez JJ
Arch Cardiovasc Dis; 2012 Nov; 105(11):593-604. PubMed ID: 23177488
[TBL] [Abstract][Full Text] [Related]
13. Newest echocardiographic techniques for the detection of cardiotoxicity and heart failure during chemotherapy.
Sawaya H; Plana JC; Scherrer-Crosbie M
Heart Fail Clin; 2011 Jul; 7(3):313-21. PubMed ID: 21749883
[TBL] [Abstract][Full Text] [Related]
14. [Cardiotoxicity induced by chemotherapy: possibilities of diagnosis].
Nagy AC; Tolnay E; Nagykálnai T; Forster T
Orv Hetil; 2004 Oct; 145(43):2171-6. PubMed ID: 15575493
[TBL] [Abstract][Full Text] [Related]
15. Severe Cardiomyopathy Due to Arthroprosthetic Cobaltism: Report of Two Cases with Different Outcomes.
Choi HI; Hong JA; Kim MS; Lee SE; Jung SH; Yoon PW; Song JS; Kim JJ
Cardiovasc Toxicol; 2019 Feb; 19(1):82-89. PubMed ID: 30143911
[TBL] [Abstract][Full Text] [Related]
16. Manage cardiac side effects of cancer treatment.
Becze E
ONS Connect; 2008 Dec; 23(12):18-9. PubMed ID: 19093341
[No Abstract] [Full Text] [Related]
17. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
[TBL] [Abstract][Full Text] [Related]
18. Reversibility of left ventricular dysfunction resulting from chemotherapy: can this be expected?
Wells QS; Lenihan DJ
Prog Cardiovasc Dis; 2010; 53(2):140-8. PubMed ID: 20728701
[TBL] [Abstract][Full Text] [Related]
19. Suspected post-chemotherapy cardiomyopathy hiding severe three-vessel coronary artery disease in a young patient with metabolic syndrome: should an early angiography be recommended?
Cecchi E; Calabretta R; Mattesini A; Gensini GF; Giglioli C
Acta Med Iran; 2012; 50(10):707-9. PubMed ID: 23275288
[TBL] [Abstract][Full Text] [Related]
20. Concepts in cardio-oncology: definitions, mechanisms, diagnosis and treatment strategies of cancer therapy-induced cardiotoxicity.
Wickramasinghe CD; Nguyen KL; Watson KE; Vorobiof G; Yang EH
Future Oncol; 2016 Mar; 12(6):855-70. PubMed ID: 26829050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
